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In both humans and mice the majority of influenzaA virus-specific, cytotoxic
T lymphocytes (CTL) recognize determinants that are shared between different
subtypes of the virus (1-3) . The nature of the antigen that was recognized
remained elusive for several years . Attempts to define it by blocking CTL target
cell recognition with monoclonal antibodies specific for individual influenza virus
proteins failed (4) . The problem was solved only when it became possible to
insert single influenza A virus proteins into target cells . This was first achieved
by transfecting cDNA copies of single-virus RNA segments (genes) into mouse
lymphoblastoid cells . It was then found that, whereas hemagglutinin was recog-
nized by rare subtype-specific CTL (5, 6), nucleoprotein was the major target
antigen for crossreacting CTL, even though nucleoprotein was present in only
very low amountson the cell surface. Yewdell et al . (7), inan alternative approach,
used recombinant vaccinia to insert a single influenza A virus gene, as cDNA,
into target cells by infection . They also found that nucleoprotein was a major
epitope . Similar results have been obtained with human CTL (8), and it has been
shown in addition that two other proteins, matrix and polymerase PB2, are
recognized .' The virus glycoprotein, hemagglutinin was seen by a minorsubpop-
ulation of subtype-specific CTL in mice (5, 6) but such a population has not been
found in humans, possibly because humans have been naturally immunized with
several strains and subtypes of influenza A viruses . Recognition of the other
glycoprotein, neuraminidase, has not been seen .
Further characterization of the influenza A virus nucleoprotein (N p)2 epitope
was made by Townsend et al . (9) who transfected truncated NP cDNA into
target cells . By using overlappingcDNA preparations, they localized the epitope
recognized by CTL ofC57 andCBA mice . These studies also showed that short
fragments of the protein could be recognized by CTL that were specific for the
virus, and that a common signal sequence was not needed to transmit protein
fragments to the membrane . These results implied that CTL, like helperT cells,
might recognize protein antigens (9) with their native conformation disrupted .
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TABLE I
Amino Acid Sequences ofPeptides Used
* The 1968 sequences were derived from the nucleoprotein of influenza
A/NT/60/68 and the 1934 sequence was from influenza A/PR/8/34
virus (11).
The single-letter amino acid code is used.
This was tested directly using synthetic peptides covering the C-terminal third
of the nucleoprotein from amino acids 325 to 487. This experimental approach
demonstrated that CTL clones from C57 mice recognized the synthetic peptide
that corresponded to residues 365-379 of nucleoprotein (10) . In addition, CTL
from one human donor, MG, which were known to recognize NP, lysed target
cells treated with another synthetic peptide 335-349 (10).
In the experiments described here, we have screened CTL prepared from
donors of other HLA types for recognition of the peptide 335-349. CTL from
three other donors sharing HLA B37 recognized this peptide, but CTL from 10
other donors did not. Continuously growing CTL lines were prepared from
lymphocytes of two of the B37+ donors, and the determinant was further
localized to stretch of eight amino acids.
Materials and Methods
Donors.
￿
Blood donors known from previous experiments (e.g., reference 8) to give an
influenza-specific CTL response in vitro were used in these experiments. We are grateful
to Dr. Frank Ennis (Worcester, MA) for the gift of the lymphocytes of donor XY and to
Dr. A. Rickinson (Birmingham, United Kingdom) for the lymphocytes of donors CD and
JD. HLA types had been determined by Dr. A. Ting (Nuffield Department of Surgery,
Oxford), using the standard National Institutes of Health technique. Lymphoblastoid cell
lines were prepared by transformation with Epstein-Barr virus as previously described (8).
Viruses. Influenza A/X31 and A/NT/60/68 viruses were grown as previously de-
scribed . The recombinant vaccinia virus, NP-VAC, in which cDNA was coding for
influenza A/PR/8/34 nucleoprotein was a gift from Dr. G. Smith and Dr. B. Moss
(National Institutes of Health, Bethesda, MD) and has been described before (7).
Induction of Influenza A Virus-specific CTL.
￿
This was carried out exactly as described
previously (8) by adding influenza A virus to peripheral blood lymphocytes in culture at
a multiplicity of infection of 1 :10. CTL were tested 1 wk after initiation of culture.
Peptides.
￿
Synthetic peptides were prepared on a synthesizer (Applied Biosystems, Inc.,
Foster City, CA) and purified by HPLC. Each peptide was at least 90% pure. Peptide
sequences were based on published information (11). The peptides used are listed in
Table I.
Treatment ofTarget Cellswith Peptides.
￿
Two methods were used as described previously
(10). In the first, CTL and "Cr (Radiochemical Center, Amersham, United Kingdom)
labeled target cells were mixed in 150 ul of RPMI 1640 with 10% FCS (Gibco-Biocult,
Paisley, United Kingdom), in microtiter wells. Peptide, diluted in RPMI 1640 was then
Peptide Virus* Sequence*
335-349 1968 SAAFEDLRVLSFIRG
336-349 1968 AAFEDLRVLSFIRG
337-349 1968 AFEDLRVLSFIRG
338-349 1968 FEDLRVLSFIRG
339-349 1968 EDLRVLSFIRG
335-349 1934 SAAFEDLRVLSFIKG
365-380 1968 IASNENMDAMESSTLEMcMICHAEL ET AL.
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TABLE II
Recognition ofNP Peptide 335-349 by Human Influenza A Virus-specific CTL
added, in a volume of 15 Al, to the required dilution. In the second method, B lympho-
blastoid cells were centrifuged and resuspended in 0.1 ml RPMI/10% FCS. An equal
volume of "Cr (3 ttCi/ml) was added followed by an equal volume of peptide to the
required concentration. After 1 h cells were washed three times in RPMI 1640, counted,
and dispensed in wells for the CTL assay.
Cytotoxicity Assay.
￿
This was carried out exactly as described previously (1, 6, 8, 10).
Cold Target Inhibition Experiments.
￿
Autologous B lymphoblastoid cells lines were in-
fected with influenza A virus or treated with peptide exactly as for preparation of target
cells but without "Cr labeling. These were added to the standard chromium-release assay
wells immediately after the effector cells to give ratios of cold inhibitor/target up to 40:1 .
Results
Recognition of Nucleoprotein Peptide 335-349 Is Strongly Associated with HLA
B37. Our initial observation was that influenza-specific CTL prepared from
one donor, MG, recognized the peptide 335-349, restricted through HLA B37
(10). Influenza A virus-specific CTL were prepared from donors known to give
a measurable response and tested on autologous or fully HLA-matched B
lymphoblastoid target cells that had been pretreated with peptide 335-349 .
Donors selected for the presence of HLA B37, normally present in 3% of the
population, were also tested. The results, shown in Table II, indicate that all 4
HLA B37-positive CTL recognized the peptide, whereas the other 10 did not.
Three other HLA B37-positive donors were tested but gave no measurable
influenza A virus-specific response and no lysis ofpeptide-treated cells. Although
two of the B37+ donors were related (LG is the daughter of MG), the others
were not related. The results suggest that the 335-349 epitope is selected directly
or indirectly by HLA B37 for CTL recognition.
Establishment of IL-2-dependent, Peptide-specific CTL Lines.
￿
Primary cultures
from MG and LG lymphocytes, stimulated for 7 d with influenza A/X31 virus,
were restimulated with equal numbers of an irradiated (3,000 rad) autologous
Donor HLA type E/T ratio
Percent lysis
autologous target
A/X31 335-349
of
cells
Nil
MG A1,31;1313,37 30:1 48 32 5
LG A1,29;B44,37 40:1 55 51 2
CD A1,2;B62,37 20:1 45 23 5
JD A1,29;B44,37 20:1 19 17 1
EG A25,30;B44,13 60:1 52 0 3
FM A2,2;B62,49 60:1 44 0 5
IH A2,3;B7,15 40:1 23 8 7
VH A1,2;B8 40:1 14 0 0
CM A1,2;B7,8 20:1 15 3 0
AB A2,3;B51,39 30:1 26 6 1
JJ A2,1 1;B35,50 60:1 35 10 14
XY A2,28;B22,35 25:1 37 14 18
JM A2,2;B15,51 40:1 25 4 9
CB A1,30;B7,44 60:1 20 1 01400
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FIGURE 1 .
￿
HLA restriction of LG CTL line grown by restimulation with the peptide 335-
349 treated LG BCL and IL-2 for 8 wk. Effectors were tested on the target BCL shown at a
2:1 ratio, each pulsed with the peptide 335-349 for 1 h at 0.4 /AM before washingand adding
to killer cells. Shared and mismatched HLA A and B antigens are shown. Results are shown
on they axis as percent specific lysis.
EBV-transformed lymphoblastoid B cell line (LBCL) that had been pulsed with
peptide 335-349 at 60 gM for 60 min. These cells were washed and then added
to CTL at a ratio of 1:1 . Supernatants from the gibbon IL-2-producing cell line
MLA144 were added to 25-30%. In both cases the cells responded by growing
and were maintained by thrice-weekly feeding with IL-2 and once-weekly addi-
tion of fresh peptide-pulsed cells. Lines were generated from each donor on
several occasions and have been maintained for >12 wk in culture without loss
of specificity .
Specificity of CTL Lines.
￿
MG and LG CTL lines maintained specificity for
peptide 335-349, lysing autologous or HLA B37-matched target cells efficiently
(>50% specific lysis) at killer/target ratios as low as 0.5 :1 . They were regularly
tested against other synthetic peptides derived from the nucleoprotein amino
acid sequence, including 365-380, and showed no crossreactivity. After growing
for 8 wk, the CTL were tested for virus specificity and HLA restriction (Fig. 1) .
They lysed autologous target cells infected with influenza A/X31 virus and NP-
vaccinia virus, but not targets infected with vaccinia virus. HLA restriction was
present in both lines and was tested extensively for the line LG. Each lympho-
blastoid target cell was pulsed with peptide 335-349. Only those that shared
B37 were lysed (Fig. 2).
Whether or not the corresponding region of the nucleoprotein was seen on
the surface of virus-infected cells was tested by cold target inhibition of CTL-
mediated lysis. Influenza A virus-infected autologous lymphoblastoid cells inhib-
ited lysis of cells that had been pulsed with peptide 335-349 (Fig. 3), indicating
that the epitope of peptide 335-349 is present on the surface of cells infected
with whole virus.
Fine Specificity of Peptide-specific CTL.
￿
MG and LG CTL lines were added to60
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FIGURE 2.
￿
Virus specificity of LG CTL line grown by restimulation with peptide 335-349
(1968)-treated LG BCL and IL-2 for 8 wk. Target cells were LG BCL, (/) infected with
influenzaA/X31 virus, (p)uninfected, (0)infected with NP-VAC,or (0)infected with vaccinia
virus. Percent specific lysis is shown on the ordinate; killer/targetratios on the abscissa.
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FIGURE 3.
￿
Influenza A virus-infected cells display theepitopeof peptide 335-349. LG CTL
were addedat a ratio of 2:1 to "Cr-labeled LG BCL that hadbeen treated with peptide 335-
349. Unlabeled LG BCL inhibitor cells which were added at ratios of 5:1 to 40:1 were either
(p) uninfected, (0) infected with influenza A/X31 virus, or (0) pulsed with peptide 335-349.
Percent specific lysis is shown on they axis.
autologous lymphoblastoid cell lines in the presence of peptide at a range of
dilutions from 0.025 to 30 AM. The titration curves shown in Fig. 4 reveal that
LG CTL recognized target cells at dilutions ofpeptide 20 times greater than did
MG CTL. This result was reproducible with CTL lines prepared on different
occasions. It suggests that the LG CTL recognized peptide on target cells with
greater efficiency than the MG CTL.
Both CTL lines were tested in a similar manner with a nested set ofpeptides
335-349 to 339-349. Both lines lysed cells pulsed with lower concentrations of1402
FIGURE 4.
￿
(0) LG and (Q) MG CTL lines were tested on MG BCLat killer to target ratio of
2:1 in the presence of peptide 335-349 at the final concentrations shown. Percent specific
lysis is shown on theyaxis.
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FIGURE 5.
￿
(") LG and (p) MG CTL lines were tested on MG BCL at a killer to target ratio
of 2:1 in the presence nested set of peptides shown. Percent specific lysis is shown on the y
axis.
336-349 than 335-349 while the peptides 337-349 and 338-349 were not
recognized as well. The 11-mer peptide 339-349 could not act as a target cell.
for either type ofCTL line (Fig. 5).
Both CTL lines reacted equally well with the peptide derived from the 1968
sequence (as used above) and the peptide derived from the 1934 sequence; these
differ only by an arginine (1968) substituted for a lysine (1934) at position 348.
Phenotype of CTL Lines.
￿
The CTL lines were stained with monoclonal anti-
bodies specific for CM, CD8, and CD3. Both lines were >90% positive for CD8,
<10% for CD4, and 95% for CD3.
In the experiments described here, influenza A virus-specific CTL from 4 of
14 human donors were found to lyse autologous target cellsthathad been treated
with the influenza nucleoprotein peptide 335-349. One of these responders,
LG, was the daughter of MG, but the others were unrelated. All were positive
for the HLA antigen, HLA B37, which suggests that this molecule plays a
dominant role in determining the fine specificity of the CTL. Three otherMcMICHAEL ET AL.
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B37+donors were tested, but it was not possible to generate influenza A virus-
specific responses from their cells; currently, we can do so from ^-30% of donors
(12) . Of the 10 influenza-specific CTL preparations that failed to recognize
autologous cells that had been treated with peptide, none was positive for HLA
B37.
It is known that CTL from at least five of the B37- donors specifically lyse
target cells infected with the recombinant vaccinia virus, NP-VAC, and thus
recognize NP in association with other HLA antigens .' These CTL must there-
fore recognize other regions of NP, or other peptide epitopes, in association
with other HLA class I antigens.
These data give strong support to the determinant selection hypothesis, which
was originally formulated to explain immune response gene function (13) and
has been extended to explain MHC class I function and polymorphism (14). The
simplest interpretation is that the HLA antigen B37 and peptide 335-349
associate in a unique way which is immunogenic to CTL. Specific but low-affinity
interactions between peptide antigens and la molecules have been described (15,
16). The finding of Townsend et al. (9) that CTL from CBA (H-2k) and C57
(H-2b) mice recognize different regions of the NP molecule also supports the
notion. However, the involvement of other polymorphic genes in epitope selec-
tion cannot be excluded.
Experiments on the specificity of CTL were facilitated by the finding that
specific CTL lines grew after restimulation with the 335-349 peptide, as shown
by irradiated autologous B lymphoblastoid cells in the presence of MLA144
supernatant (IL-2). The rapid growth of the CTL in this manner contrasts with
the difficulty that we have encountered in the past in growing CD8+ CTL on
influenza virus-infected cells. The CTL lines were >90% positive for the CD8
antigen, and were therefore distinct from the CD4 cytolytic T cell clones that
recognize NP, as described by Fleischer et al. (17).
The CTL lines were specific for the 335-349 peptide. They were regularly
tested against the 365-380 peptide, which is seen by the murine CTL, and also
other peptides, with negative results. The CTL lines maintained their ability to
kill virus-infected cells that show specificity for nucleoprotein when recombinant
vaccinia virus was used to infect targets. The relationship between the epitope
defined by peptide 335-349 and that presented on the surface of influenza A
virus-infected cells was further explored by cold target-cell inhibition. It was
found that influenza virus-infected cells could inhibit recognition of peptide-
treated cells by the CTL line, though less efficiently than unlabeled peptide-
treated cells. This indicates that this epitope is represented on the surface of
influenza virus-infected cells.
The CTL lines also maintained their HLA specificity. Several HLA-mis-
matched target cells were pulsed with peptide and tested for lysis. None was seen
confirming the unique association with B37. The results also failed to reveal any
alloreactivity by these T cells, which, although not monoclonal, shared recogni-
tion of precisely defined antigens (18).
The fine specificity of recognition was further analyzed by testing CTL with
related peptides. Both CTL lines crossreacted fully with the 1934 peptide that
differs in the amino acid at position 348 (11). When the amino-terminal residues1404
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were removed, the recognition wasimproved for peptide 336-347 for both CTL
lines. Removal of amino acids 336 and 337 gave results very similar to the full-
length peptide, but removal of the phenylalanine at position 338 abolished
activity. This indicates that the most critical residues for T cell recognition
probably lie between residues 339 and 347.
The efficiency of recognition of peptide differed between the two lines. The
LG CTL line recognized 20-fold less peptide than did the MG CTL. Thus,
although both lines recognized peptide in association with the same HLAantigen,
there may be at least two ways of doing this. This could reflect a molecular
difference in the T cell receptor combinations used by clones within the two
lines. However, we cannot assume an affinity difference without direct binding
measurements ; other explanations for the finding, such as differences in T cell
mobility or activation state, are possible .
These results have a practical implication. Attempts are currently being made
to synthesize peptides based on virus protein sequences for possible use as
vaccines. Forstimulation of CTL activity, at least, we could not expect any single
peptide to be very efficient; the 335-349 peptide should only stimulate CTL in
the 3% of the population that are positive for HLA B37. Although CTL are
probably less important than antibody in conferring prophylactic immunity to
influenza, they do have a well-defined role to play in clearance of virus (reviewed
in 19) and, unlike antibody, could offer subtype-crossreactive protection.
In conclusion, these results define an epitope on the influenza A virus nucleo-
protein that is recognized by CTL of individuals who are positive for HLA B37.
The close association between the epitope and HLA B37, and the fact that we
have not been able to identify other haplotypes that recognize this region imply
that each HLA antigen will present a set of peptide fragments of foreign proteins
to CTL, and that each set will differ. Thus HLA type must have a qualitative
effect on the nature of an individual's CTL response. It will be important to
define the variety of peptides with which a given HLA antigen can interact,
because this may determine the extent of the HLA polymorphism needed for
survival in a potentially hostile environment.
Summary
Human influenza A virus-specific, cytotoxic T cells have been shown previ-
ously to recognize the virus nucleoprotein on infected cells. CTL preparations
from four HLA B37-positive donors were shown to recognizea synthetic peptide
that corresponded to amino acids 335-349 of the nucleoprotein sequence .
Influenza-specific CTL from 10 donors of other HLA types failed to recognize
this epitope. CD8+ CTL lines were derived from lymphocytes of two HLA B37-
positive donors and used to show that the peptide was represented on virus-
infected cells and to determine the probable boundaries of the epitope.
We thank Dr. A. R. M. Townsend (Oxford, United Kingdom) for several helpful
discussions and Miss Claire Edmans for preparing the manuscript.
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Note added in proof Since this manuscript was submitted we have tested influenza A virus-specific
CTL from four more donors for recognition of NP peptide 335-349. Two that were positive for
HLA B37 lysed autologous peptide-treated cells to levels comparable with MG CTL; two that were
negative for HLA B37 failed to kill peptide-treated target cells.
References
1 . McMichael, A. J., and B. A. Askonas. 1978. Influenza virus specific cytotoxic T cells
in man : induction and properties of the cytotoxic cell. Eur. J. Immunol. 8:705.
2. Biddison, W. E., S. Shaw, and D. L. Nelson. 1981 . Virus specificity ofhuman influenza
virus immune cytotoxic T cells.J. Immunol. 122 :660.
3. Zweerink, H . J., S. A. Courtneidge, J. J. Skehel, M. J . Crumpton, and B. A. Askonas.
1977 . Cytotoxic T cells kill influenza virus-infected cells but do not distinguish
between serologically distinct type A viruses. Nature (Lond.). 267:354.
4. Dongworth, D. W., and A. J. McMichael. 1984. Inhibition of human T lymphocyte
function with monoclonal antibodies. Br. Med. Bull. 40:254.
5. Braciale, T. J., V. L. Braciale, T. J. Henkel, J. Sambrook, and M. J . Gething. 1984.
Cytotoxic T lymphocyte recognition of the influenza haemagglutinin gene product
expressed by DNA mediated gene transfer. .). Exp. Med. 159:341 .
6. Townsend, A . R. M ., A. J. McMichael, N . P . Carter, J. A. Huddleston, and G. G.
Brownlee. 1984. Cytotoxic T cell recognition of the influenza nucleoprotein and
haemagglutinin expressed in transfected mouse L cells. Cell. 39:13.
7. Yewdell, J. W ., J. R. Bennink, G. L. Smith, and B. Moss. 1985 . Influenza A virus
nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus
cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 82:1785.
8. McMichael, A. J., C. A. Michie, F. M. Gotch, G. L. Smith, and B . Moss. 1986 .
Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes.
J. Gen. Virol. 67:719.
9. Townsend, A. R. M., F. M. Gotch, and J. Davey. 1985 . Cytotoxic T cells recognise
fragments of influenza nucleoprotein . Cell. 42:457.
10 . Townsend, A. R. M., J . Rothbard, F. M . Gotch, G. Bahadur, D. Wraith, and A. J.
McMichael . 1986. The epitopes of influenza nucleoprotein recognised by cytotoxic
T lymphocytes can be defined with short synthetic peptides. Cell. 44:959.
11 . Winter, E., and S. Fields. 1981 . The structure ofthe gene encoding the nucleoprotein
of human influenza virus A/PR/8/34. Virology. 114:423.
12. McMichael, A. J., F. M . Gotch, D. W. Dongworth, A. Clarke, and C. W. Potter.
1983. Declining T cell immunity to influenza. Lancet. ii:762.
13. Fleischer, B., H . Becht, and R. Rott. 1985 . Recognition of viral antigens by human
influenza A virus specific T lymphocyte clones. J. Immunol. 135 :2800.
14. Hunig, T. R., and M. J. Bevan . 1982. Antigen recognition by cloned cytotoxic T
lymphocytes follow rules predicted by the altered self-hypothesis. J. Exp. Med.
155 :111 .
15 . Babbitt, B. P., P. M. Allen, G. Matsueda, E. Haber, and E. R. Unanue. 1985 . Binding
of immunogenic peptides to la histocompatibility molecules. Nature (Lond.). 317 :359.
16 . Watts, T. H., H. E. Gaub, and H. M. McConnell. 1986. T cell mediated association
of peptide antigen and major histocompatibility complex protein detected by energy
transfer in an evanescent wave-field. Nature (Loud.). 320:179.
17 . Rosenthal, A. S., M . A . Barcinski, and J . T. Blake. 1977. Determinant selection is a
macrophage dependent immune response gene function. Nature (Lond.). 267:156.
18 . Vitello, A ., and L. A. Sherman. 1983. Recognition of influenza infected cells by
cytotoxic T lymphocyte clones : determinant selection by Class I restriction elements.
J. Immunol. 131 :1635 .1406
￿
EPITOPE SELECTION BY HLA B37
19. Askonas, B. A., A. J. McMichael, and R. G. Webster. 1982 . The immune response
to influenza viruses and the problem of protection against infection. In Basic and
Applied Influenza Research. A. S. Beare, editor. CRC Press, Inc., Boca Raton, FL.
159-188.